BaseSpace
Correlation
Engine-Public
Sign In
Register
Correlation Engine 2.0
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
Angiogenesis
,
Inflammatory disorder
,
Hippocampus
,
Neocentromeres
,
Lovastatin
,
FXYD4
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
chronic myelogenous leukemia
Summary
General Info
Curated Studies
Most Correlated Studies
MSC from BM-MNC of essential thrombocythemia, polycythemia vera or chronic myeloid leukemia patients
Induced pluripotent stem cells from imatinib-sensitive chronic myelogenous leukemia samples
Pre-B cells of Swiss Webster mice with Stat5a/b conditional knockout
Chronic myelogenous leukemia cells in normoxic or hypoxic culture treated with imatinib
Leukemic cells (K562) with 20uM iron (Fe-III) mesoporphyrin or mesoporphyrin alone for 20hr
Explore Curated Studies Results
Literature
Most Relevant Literature
SIRT1 deacetylase promotes acquisition of genetic mutations for drug resistance in CML cells.
Synergistic killing effect of imatinib and simvastatin on imatinib-resistant chronic myelogenous leu…
Chronic myelogenous leukemia presenting in blast phase with nodal, bilineal myeloid sarcoma and T-ly…
Biological effects of decreasing RBM15 on chronic myelogenous leukemia cells.
Chronic myelogenous leukemia].
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
Imatinib Mesylate and Decitabine in Treating Patients With Chronic Myelogenous Leukemia
Imatinib Mesylate in Treating Patients With Chronic Myelogenous Leukemia
Natural History Study of Patients With Chronic Myelogenous Leukemia
Troxacitabine in Treating Patients With Chronic Myelogenous Leukemia
Bortezomib in Treating Patients With Chronic Myelogenous Leukemia
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ